abrdn Life Sciences Investors Q2 2025 Commentary
Source: SeekingAlpha
2025-09-09 14:32:00 ET
Fund performance
The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotechnology Index. 1 ...
Read the full article on Seeking Alpha
For further details see:
abrdn Life Sciences Investors Q2 2025 Commentary
TeklaLife Sciences Investors
NASDAQ: HQL
HQL Trading
0.3% G/L:
$16.82 Last:
81,563 Volume:
$16.78 Open:
HQL Latest News
February 10, 2026 04:17:00 pm
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
February 02, 2026 05:00:50 am
This Top AI Trade for 2026 Pays a Huge 11.6% Dividend (It's Not a Tech Stock)
June 30, 2025 04:17:00 pm
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
